TWO SIGMA INVESTMENTS, LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,848,045
-76.1%
67,031
-73.9%
0.01%
-73.7%
Q2 2023$7,732,214
+2.2%
257,226
+23.2%
0.02%
-13.6%
Q1 2023$7,564,969
+53.0%
208,804
+50.6%
0.02%
+37.5%
Q4 2022$4,944,468
+41.8%
138,617
+34.5%
0.02%
+33.3%
Q3 2022$3,488,000
+487.2%
103,048
+460.4%
0.01%
+500.0%
Q1 2022$594,000
-50.0%
18,389
-52.4%
0.00%
-33.3%
Q2 2021$1,188,000
-81.9%
38,592
-84.6%
0.00%
-82.4%
Q1 2021$6,555,000
+347.4%
250,367
+329.8%
0.02%
+325.0%
Q4 2020$1,465,000
-79.1%
58,247
-80.3%
0.00%
-88.6%
Q2 2020$7,005,000
+88.2%
294,948
+42.5%
0.04%
+16.7%
Q1 2020$3,723,000
+88.9%
206,962
+149.1%
0.03%
+400.0%
Q4 2019$1,971,000
-61.5%
83,086
-46.3%
0.01%
-64.7%
Q2 2019$5,120,000
-58.1%
154,739
-55.6%
0.02%
-57.5%
Q1 2019$12,216,000
+209.3%
348,623
+304.2%
0.04%
+207.7%
Q1 2018$3,950,000
+48.5%
86,249
+29.2%
0.01%
+44.4%
Q4 2017$2,660,000
+1041.6%
66,760
+1135.6%
0.01%
+800.0%
Q2 2017$233,000
-36.3%
5,403
-80.2%
0.00%
-50.0%
Q4 2015$366,000
-86.0%
27,234
-87.4%
0.00%
-84.6%
Q1 2015$2,613,000
+298.3%
216,110
+173.3%
0.01%
+225.0%
Q4 2014$656,000
-27.4%
79,077
-34.1%
0.00%
-20.0%
Q4 2013$904,000119,9260.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 921,962$33,402,6835.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 423,500$15,326,4654.28%
ARMISTICE CAPITAL, LLC 4,350,000$157,600,5002.27%
S&T BANK/PA 223,775$8,1071.46%
Aristotle Capital Boston, LLC 1,155,149$41,851,0711.29%
Tributary Capital Management, LLC 353,671$12,813,5001.19%
Bridge City Capital, LLC 62,790$2,274,8821.14%
RICE HALL JAMES & ASSOCIATES, LLC 551,285$19,973,0561.14%
Intrinsic Edge Capital Management LLC 289,704$10,495,9761.05%
Parkman Healthcare Partners LLC 131,878$4,777,9401.04%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders